Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies.
Peters I, Dubrowinskaja N, Abbas M, Seidel C, Kogosov M, Scherer R, Gebauer K, Merseburger AS, Kuczyk MA, Grünwald V, Serth J. Peters I, et al. Among authors: gebauer k. PLoS One. 2014 Mar 14;9(3):e91440. doi: 10.1371/journal.pone.0091440. eCollection 2014. PLoS One. 2014. PMID: 24633192 Free PMC article.
Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.
Dubrowinskaja N, Gebauer K, Peters I, Hennenlotter J, Abbas M, Scherer R, Tezval H, Merseburger AS, Stenzl A, Grünwald V, Kuczyk MA, Serth J. Dubrowinskaja N, et al. Among authors: gebauer k. Cancer Med. 2014 Apr;3(2):300-9. doi: 10.1002/cam4.181. Epub 2014 Jan 27. Cancer Med. 2014. PMID: 24464810 Free PMC article.
Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis of the Scalp: Week 52 Results From a Phase 3b, Randomized, Double-Blind, Placebo-Controlled Trial.
Sofen HL, Gebauer K, Spelman L, Yamauchi PS, Yao SL, Nishandar T, Kopeloff I, Crane M, Gogineni R, Kothekar M, Bagel J. Sofen HL, et al. Among authors: gebauer k. J Am Acad Dermatol. 2024 Dec 23:S0190-9622(24)03393-0. doi: 10.1016/j.jaad.2024.12.018. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39722400 Free article.
Australasian hidradenitis suppurativa management guidelines.
Frew J, Smith A, Penas PF, Ellis E, Foley P, Rubel D, McMeniman E, Marshman G, Saunders H, Veysey E, Nicolopolous J, Spelman L, Gebauer K. Frew J, et al. Among authors: gebauer k. Australas J Dermatol. 2024 Nov 22. doi: 10.1111/ajd.14388. Online ahead of print. Australas J Dermatol. 2024. PMID: 39578415
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.
Caron AGM, van Huizen AM, Musters AAH, Gerbens LAA, Middelkamp Hup MA, Flohr C, Irvine AD, Vestergaard C, Peris K, Brandling-Bennett HA, Drucker AM, Spuls PI; MTX Consensus for AD Survey Study Group. Caron AGM, et al. J Eur Acad Dermatol Venereol. 2024 Aug 1. doi: 10.1111/jdv.20271. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39087636
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators. Ray KK, et al. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199. Eur J Prev Cardiol. 2024. PMID: 38861400
120 results